Versor Investments’s West Pharmaceutical WST Stock Holding History

Versor Investments’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-890	Closed	-$245K	–	582
2025 Q4	$245K	Sell	890 -25	-3%	-$6.84K	0.04%	512
2025 Q3	$240K	Buy	+915	New	+$222K	0.04%	551
2024 Q1	–	Sell	-4,070	Closed	-$1.43M	–	912
2023 Q4	$1.43M	Buy	+4,070	New	+$1.44M	0.29%	59
2023 Q3	–	Sell	-1,387	Closed	-$530K	–	854
2023 Q2	$530K	Buy	+1,387	New	+$495K	0.09%	241
2022 Q4	–	Sell	-1,593	Closed	-$392K	–	1009
2022 Q3	$392K	Sell	1,593 -1,296	-45%	-$395K	0.02%	522
2022 Q2	$874K	Buy	2,889 +1,089	+61%	+$354K	0.03%	295
2022 Q1	$739K	Buy	+1,800	New	+$705K	0.03%	207
2020 Q3	–	Sell	-1,900	Closed	-$432K	–	339
2020 Q2	$432K	Buy	+1,900	New	+$373K	0.04%	99

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Versor Investments's WST Position: Q1 2026 in Review

Versor Investments sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 890 shares — an estimated $245K sold.

Versor Investments first reported a position in WST in Q2 2020 and held it in 8 quarters. The position peaked at $1.43M in Q4 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Versor Investments reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 890 West Pharmaceutical shares in Q1 2026, an estimated $245K.
Versor Investments first reported a position in West Pharmaceutical in Q2 2020 and held it in 8 quarters.
Versor Investments's West Pharmaceutical position peaked at $1.43M in Q4 2023.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.